Buprenorphine Dispensing in Pennsylvania During the COVID-19 Pandemic, January to October 2020

J Gen Intern Med. 2021 Dec;36(12):3915-3917. doi: 10.1007/s11606-021-07083-y. Epub 2021 Aug 10.

Rohan Chalasani^{1

2}, Jared M Shinabery³, Carrie Thomas Goetz³, Chung-Chou H Chang⁴, Qingnan Yang², Katie J Suda^{2

4}, Walid F Gellad^{5

6}

¹ Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
² Center for Pharmaceutical Policy and Prescribing, Health Policy Institute, University of Pittsburgh, Pittsburgh, PA, USA.
³ Drug Surveillance and Misuse Prevention Office, Pennsylvania Department of Health, Harrisburg, PA, USA.
⁴ Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
⁵ Center for Pharmaceutical Policy and Prescribing, Health Policy Institute, University of Pittsburgh, Pittsburgh, PA, USA. walid.gellad@pitt.edu.
⁶ Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. walid.gellad@pitt.edu.

No abstract available

Publication types